Cagrilintide and retatrutide are two investigational peptide-based medicines currently being studied for the treatment of obesity and related metabolic conditions
Guo C, Lu H, Gao W, Wang L, Lu K, Wu S, Pataer A, Huang M, El-Zein R, Lin T, Roth JA, Mehran R, Hofstetter W, Swisher SG , Wu X, Fang B
There is currently limited scientific evidence that IV infusions provide general health, "wellness", energy, immune, detox or anti-ageing benefits in people who do not have a diagnosed deficiency or medical need, and we cannot guarantee any particular result individual responses vary
This dynamic modification is installed by m6A methyltransferases (writers) and removed by demethylases (erasers) such as ALKBH5